A significant development in recent days has seen a number of patients become reinfected with Covid 19. But what does the development mean in the race for a vaccine, can a vaccine defend against multiple potential strains of the virus? To discuss we were joined on the show by Paul Moynagh Professor of Immunology and Director of the Kathleen Lonsdale Institute for Human Health research at Maynooth University.
